Max Planck Society - eDoc Server

http://edoc.mpg.de



Characterization of p53 activator compounds which inhibit a survival factor kinase as well
Authors: Belle, R.; Baska, F.; Orfi, Z.; Szantai-Kis, C.; Sipos, A.; Breza, N.; Borbely, G.; Penzes, K.; Orfi, L.; Keri, G.
Date of Publication (YYYY-MM-DD): 2012-09
Title of Journal: FEBS Journal
Volume: 279
Issue / Number: Suppl. 1 Sp. Iss.
Start Page: 179
End Page: 179
Document Type: Article
ID: 625646.0


SIGNAL TRANSDUCTION THERAPY OF TUMORS WITH MULTIPLE TARGET KINASE INHIBITORS
Authors: Keri, G.; Orfi, L.; Greff, Z.; Varga, Z.; Szokol, B.; Horvath, Z.; Petak, I. P.; Ullrich, A.
Date of Publication (YYYY-MM-DD): 2008-09
Title of Journal: Anticancer Research
Volume: 28
Issue / Number: 5C
Start Page: 332
Document Type: Article
ID: 397204.0


AXL is a potential target for therapeutic intervention in breast cancer progression
Authors: Zhang, Y. X.; Knyazev, P. G.; Cheburkin, Y. V.; Sharma, K.; Knyazev, Y. P.; Orfi, L.; Szabadkai, I.; Daub, H.; Keri, G.; Ullrich, A.
Date of Publication (YYYY-MM-DD): 2008-03-15
Title of Journal: Cancer Research
Volume: 68
Issue / Number: 6
Start Page: 1905
End Page: 1915
Document Type: Article
ID: 353959.0


Signal transduction therapy with rationally designed kinase inhibitors
Authors: Keri, G.; Orfi, L.; Eros, D.; Hegymegi-Barakonyi, B.; Szantai-Kis, C.; Horvath, Z.; Waczek, F.; Marosfalvi, J.; Szabadkai, I.; Pato, J.; Greff, Z.; Hafenbradl, D.; Daub, H.; Muller, G.; Klebl, B.; Ullrich, A.
Date of Publication (YYYY-MM-DD): 2006-01
Title of Journal: Current Signal Transduction Therapy
Volume: 1
Issue / Number: 1
Start Page: 67
End Page: 95
Document Type: Article
ID: 318840.0


Prediction oriented QSAR modelling of EGFR inhibition
Authors: Szantai-Kis, C.; Kovesdi, I.; Eros, D.; Banhegyi, P.; Ullrich, A.; Keri, G.; Orfi, L.
Date of Publication (YYYY-MM-DD): 2006
Title of Journal: Current Medicinal Chemistry
Volume: 13
Issue / Number: 3
Start Page: 277
End Page: 287
Document Type: Article
ID: 288905.0


Proteomic characterization of the angiogenesis inhibitor SU6668 reveals multiple impacts on cellular kinase signaling
Authors: Godl, K.; Gruss, O. J.; Eickhoff, J.; Wissing, J.; Blencke, S.; Weber, M.; Degen, H.; Brehmer, D.; Orfi, L.; Horvath, Z.; Keri, G.; Muller, S.; Cotten, M.; Ullrich, A.; Daub, H.
Date of Publication (YYYY-MM-DD): 2005-08-01
Title of Journal: Cancer Research
Volume: 65
Issue / Number: 15
Start Page: 6919
End Page: 6926
Document Type: Article
ID: 264844.0


Characterization of a conserved structural determinant controlling protein kinase sensitivity to selective inhibitors
Authors: Blencke, S.; Zech, B.; Engkvist, O.; Greff, Z.; Orfi, L.; Horvath, Z.; Keri, G.; Ullrich, A.; Daub, H.
Date of Publication (YYYY-MM-DD): 2004-05
Title of Journal: Chemistry & Biology
Volume: 11
Issue / Number: 5
Start Page: 691
End Page: 701
Document Type: Article
ID: 217613.0